Everand Logo

Welcome to Everand!

  • Newsweek

    Atomwise's Abraham Heifets Uses AI to Speed the Development of Medications

    Abraham Heifets is using artifical intelligence to ensure the safety of cancer patients while they undergo treatment.
    by Noah Miller Jul 26, 2019 3 minutes
    FE_Cancer_Moonshot
    FE_Cancer_Moonshot

    Abraham Heifets is the CEO and co-founder of Atomwise, a biotech company using patented deep learning artificial intelligence technology to predict and discover which drugs will be better, safer and more potent for cancer patients.

    What is your moonshot? To make novel, better and safer drugs, with the ultimate goal to get medicines into the hands of patients faster.

    How do you do that? We're trying to solve how you modify a cell that's in the runaway

    You’re reading a preview, subscribe to read more.

    More from Newsweek

    Newsweek1 min read
    Living On The Edge
    An 18th-century cottage clings to the precipice following a dramatic cliff fall in the coastal village of Trimingham on April 8. The homeowner, who bought the property in 2019 for around $165,000, will now see the structure demolished as the saturate
    Newsweek1 min readInternational Relations
    Senseless Strike
    Mourners gather at Saif Abu Taha’s funeral on April 2. Taha and six other World Central Kitchen staff members were killed the prior night in an Israeli drone strike. The Israel Defense Forces took responsibility for mistakenly targeting the convoy, c
    Newsweek1 min read
    Flower Power
    A woman walks through a field of vibrant tulips near Milan on April 4. Dutch couple Edwin Koeman and Nitsuhe Wolanios opened the flower farm in 2017 to share their passion for tulips with Italy. There are now over 500,000 flowers in 450 varieties ove

    Related Books & Audiobooks